263 related articles for article (PubMed ID: 24832867)
1. Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors.
Cheng J; Xiong Z; Duffney LJ; Wei J; Liu A; Liu S; Chen GJ; Yan Z
Biol Psychiatry; 2014 Dec; 76(12):953-62. PubMed ID: 24832867
[TBL] [Abstract][Full Text] [Related]
2. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptors.
Gronier B
Eur Neuropsychopharmacol; 2011 Feb; 21(2):192-204. PubMed ID: 21146374
[TBL] [Abstract][Full Text] [Related]
3. Treatment with a clinically-relevant dose of methylphenidate alters NMDA receptor composition and synaptic plasticity in the juvenile rat prefrontal cortex.
Urban KR; Li YC; Gao WJ
Neurobiol Learn Mem; 2013 Mar; 101():65-74. PubMed ID: 23333502
[TBL] [Abstract][Full Text] [Related]
4. Receptor and circuit mechanisms underlying differential procognitive actions of psychostimulants.
Spencer RC; Berridge CW
Neuropsychopharmacology; 2019 Sep; 44(10):1820-1827. PubMed ID: 30683912
[TBL] [Abstract][Full Text] [Related]
5. Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors.
Di Miceli M; Gronier B
Psychopharmacology (Berl); 2015 Jun; 232(12):2191-205. PubMed ID: 25572531
[TBL] [Abstract][Full Text] [Related]
6. Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex.
Chen L; Yang CR
J Neurophysiol; 2002 May; 87(5):2324-36. PubMed ID: 11976371
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action.
Zhang CL; Feng ZJ; Liu Y; Ji XH; Peng JY; Zhang XH; Zhen XC; Li BM
PLoS One; 2012; 7(12):e51910. PubMed ID: 23284812
[TBL] [Abstract][Full Text] [Related]
8. Methylphenidate amplifies long-term potentiation in rat hippocampus CA1 area involving the insertion of AMPA receptors by activation of β-adrenergic and D1/D5 receptors.
Rozas C; Carvallo C; Contreras D; Carreño M; Ugarte G; Delgado R; Zeise ML; Morales B
Neuropharmacology; 2015 Dec; 99():15-27. PubMed ID: 26165920
[TBL] [Abstract][Full Text] [Related]
9. β3-adrenoceptor activation exhibits a dual effect on behaviors and glutamate receptor function in the prefrontal cortex.
Sun X; Wang X; Zhou HC; Zheng J; Su YX; Luo F
Behav Brain Res; 2021 Aug; 412():113417. PubMed ID: 34157371
[TBL] [Abstract][Full Text] [Related]
10. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
Kodama T; Kojima T; Honda Y; Hosokawa T; Tsutsui KI; Watanabe M
J Neurosci; 2017 Mar; 37(9):2387-2394. PubMed ID: 28154152
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.
Gamo NJ; Wang M; Arnsten AF
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1011-23. PubMed ID: 20855046
[TBL] [Abstract][Full Text] [Related]
12. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness.
Devilbiss DM; Berridge CW
Biol Psychiatry; 2008 Oct; 64(7):626-35. PubMed ID: 18585681
[TBL] [Abstract][Full Text] [Related]
13. Possible involvements of glutamate and adrenergic receptors on acute toxicity of methylphenidate in isolated hippocampus and cerebral cortex of adult rats.
Motaghinejad M; Motevalian M; Shabab B
Fundam Clin Pharmacol; 2017 Apr; 31(2):208-225. PubMed ID: 27739173
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Methylphenidate (Ritalin) on the Neurophysiology of the Monkey Caudal Prefrontal Cortex.
Tremblay S; Pieper F; Sachs A; Joober R; Martinez-Trujillo J
eNeuro; 2019; 6(1):. PubMed ID: 30847388
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic α₁ - and α₂-receptors.
Berridge CW; Shumsky JS; Andrzejewski ME; McGaughy JA; Spencer RC; Devilbiss DM; Waterhouse BD
Biol Psychiatry; 2012 Mar; 71(5):467-73. PubMed ID: 21890109
[TBL] [Abstract][Full Text] [Related]
16. Methylphenidate affects task-switching and neural signaling in non-human primates.
Rajala AZ; Populin LC; Jenison RL
Psychopharmacology (Berl); 2020 May; 237(5):1533-1543. PubMed ID: 32067136
[TBL] [Abstract][Full Text] [Related]
17. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.
Berridge CW; Devilbiss DM; Andrzejewski ME; Arnsten AF; Kelley AE; Schmeichel B; Hamilton C; Spencer RC
Biol Psychiatry; 2006 Nov; 60(10):1111-20. PubMed ID: 16806100
[TBL] [Abstract][Full Text] [Related]
18. Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia.
Rotaru DC; Yoshino H; Lewis DA; Ermentrout GB; Gonzalez-Burgos G
J Neurosci; 2011 Jan; 31(1):142-56. PubMed ID: 21209199
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area.
Prieto-Gómez B; Vázquez-Alvarez AM; Martínez-Peña JL; Reyes-Vázquez C; Yang PB; Dafny N
Life Sci; 2005 Jun; 77(6):635-49. PubMed ID: 15921995
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory.
Yuen EY; Liu W; Karatsoreos IN; Ren Y; Feng J; McEwen BS; Yan Z
Mol Psychiatry; 2011 Feb; 16(2):156-70. PubMed ID: 20458323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
